JUMP REPORT
| Avg Daily Volume: 1,291,993 Market Cap: 10.95B Sector: Healthcare Short Interest: 1.42 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .75/share REV: 1, 090/M
___________________________________________________________
LAST QTR: EPS: .50/share ACTUAL: .57/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .56/share REV: 975.9/M
______________________________________________________
FULL YR: EPS: 2.46/share REV: 4,000/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 53% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 8.2, -7.74, 8.5
EXPECTED JUMP MOVE: 10%
Links To Latest News and Headlines
CHARLOTTE, N.C., May 26, 2026 (GLOBE NEWSWIRE) — Dentsply Sirona (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced the strengthening of its U.S. distribution footprint through an expanded partnership with Nashville Dental, Inc (NDI), a leading independent dental distributor serving the Southeast and Mid-Atlantic regions. As of August 1, 2026, NDI’s portfolio will include Dentsply Sirona’s full range of connected techno
CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 27, 2026, at 3:35 p.m. ET. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsply
A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with service-sector prices rising at their fastest pace in four years.
Dentsply Sirona’s first quarter results reflected a company in the midst of operational transformation, with revenue holding steady year over year but outperforming Wall Street’s expectations. Management attributed the quarter’s performance to both ongoing restructuring efforts and investments in commercial capabilities, noting that early momentum is visible in customer engagement and new distribution partnerships. CEO Daniel T. Scavilla described the business as “in transition,” emphasizing tha
DENTSPLY SIRONA (NasdaqGS:XRAY) launched Smart View, Detect, the first FDA cleared AI powered CBCT diagnostic aid for dental imaging. The company expanded its U.S. distribution agreement with Atlanta Dental Supply to broaden access to its digital dentistry solutions. DENTSPLY SIRONA is pushing further into digital dentistry at a time when its share price, at $10.96, reflects a challenging period for investors. The stock has seen a 28.5% decline over the past year and a very large drop over…
StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.